MTDH and breast carcinoma: At titers of ≥1:50 anti-AEG-1 antibody was detected in 49% of these patients, including 45% breast cancer, 50% HCC, 49% colorectal cancer, 45% lung cancer and 49% gastric cancer patients, with none of 230 normal individuals displaying positivity (p < 0.01) [133].